Pricing Log in Create free account

PolyPid Ltd. (PYPD) vs Unicycive Therapeutics, Inc. (UNCY)

PolyPid Ltd. and Unicycive Therapeutics, Inc. are both Biotechnology companies. PolyPid Ltd. and Unicycive Therapeutics, Inc. are of similar size ($100.0M and $99.5M). Across the 8 metrics below, Unicycive Therapeutics, Inc. leads on 6 and PolyPid Ltd. on 2.

Valuation

Metric PYPD UNCY Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 19.96 1.70 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (31.16%) (52.08%) (33.15%)
Free cash flow yield (71.51%) (30.79%) (25.50%)

Profitability

Metric PYPD UNCY Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (243.59%) (101.07%) (56.36%)
Return on assets (119.05%) (69.05%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PYPD UNCY Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 57.43% 70.18% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PYPD UNCY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.35 3.81 4.72
Net debt to EBITDA 0.39 1.43 0.96

Dividend

Metric PYPD UNCY Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PYPD UNCY Biotechnology median
Market cap 99.53m 100.00m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack